BATM, a provider of technologies for medical laboratory systems, has developed a new diagnostics kit to detect COVID-19.

The kit, developed by BATM’s biomedical division, has undergone testing by several central laboratories and hospitals that have now verified its ability to diagnose COVID-19.

The group has begun production of the kit at its Adaltis facility in Rome and is working with academic and research institutions, mainly in Europe, to prepare for large-scale production. 

The kit, which supports all the Centers for Disease Control and Prevention recommendations, has already received interest from customers in several countries.

Zvi Marom, chief executive officer of BATM, said: “We believe that the strategy we adopted in our biomedical division is proving to be correct, especially in light of the current COVID-19 outbreak. We are now able to quickly provide diagnostic kits for any new pathogen that appears.”

He added: “We have already received extremely positive feedback and significant interest from several leading medical institutions that have started testing the first panel of Ador’s NATlab solution and adding COVID-19 will greatly strengthen its appeal and value.”

Date published: February 27, 2020

Subscriber content

To get unlimited access subscribe today


Already a subscriber? Login